Advaxis Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Advaxis Inc.

Advaxis Inc. | Mutual Funds

Mutual Funds that own Advaxis Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

PZU FIO Parasolowy - Energia Medycyna Ekologia

830,000

1.57%

61,760

1.41%

06/30/2017

Vanguard Total Stock Market Index Fund

824,712

1.56%

07/31/2018

Vanguard Extended Market Index Fund

691,781

1.31%

07/31/2018

Bridgeway Ultra Small Company Market Fund

183,400

0.35%

83,400

0.06%

12/31/2017

Fidelity Spartan Extended Market Index Fund

152,732

0.28%

07/31/2018

Dash Foreign Stocks

136,945

0.26%

0.44%

06/28/2018

Schwab US Small Cap ETF

133,190

0.25%

09/06/2018

iShares Micro Cap ETF

127,690

0.24%

0.02%

09/06/2018

Avance Global, FI

122,545

0.23%

122,545

0.27%

12/31/2017

Vanguard Health Care Index Fund

118,428

0.22%

936

07/31/2018

About Advaxis

View Profile

Address	305 College Road East Princeton New Jersey 08540 United States
Employees	-
Website	http://www.advaxis.com
Updated	07/08/2019
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy, and hotspot mutation therapy.